Start main page content

South Africa’s second COVID-19 vaccine trial explained

- Wits University

Pasha 78: Listen to Professor Shabir Madhi, explaining how the new vaccine trial will work

Trials have begun in South Africa for a second COVID-19 vaccine study. The hope is that at least one of the vaccines being trialled will show promise and play a role in eliminating the SARS-CoV-2 coronavirus.

In this episode of Pasha, Shabir Madhi, professor of vaccinology and Director of the MRC Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, explains why there are multiple vaccine studies under way, the differences between them, how this second South African trial works and when the results might be known.


Read more: Pasha 71: COVID-19 vaccine trial in South Africa explained